Results 131 to 140 of about 26,059 (187)

External Validation of the MicroSimulation Core Obesity Model (MS-COM) to Predict Cardiovascular Outcomes, Mortality and Type 2 Diabetes Mellitus Incidence and Assess Cost Effectiveness. [PDF]

Pharmacoeconomics
Fawsitt CG, Thom H, Aceituno D, Jarde A, Larsen S, Lübker C, Kayongo E, Keeney E, Foos V.   +8 more
europepmc   +1 more source

Comparing the Influence of Heterogeneity on Model Outcomes in Individual-Level and Cohort Simulations: An Exploratory Simulation Study. [PDF]

Pharmacoeconomics
van Well EB, Govers TM, Koffijberg H.
europepmc   +1 more source

How policymakers value end-of-life treatments for rare and common diseases in China: evidence from a contingent valuation study. [PDF]

Glob Health Res Policy
Cheng H, Jiang S, Liu T, Li B, Chen S, Li A, Chen H, Wang H, Gu Y.   +8 more
europepmc   +1 more source

Translation, cross-cultural adaptation and psychometric validation of the Chinese version of Facial Clinimetric Evaluation Scale (FaCE) and Facial Disability Index (FDI). [PDF]

BMJ Open Qual
Chen M, Wang Y, Gu Z, Guo J, Cui W, Zhao B, Cai Z, Liu Q, Jiang Z.   +8 more
europepmc   +1 more source

The online purchase of medicines - an international pharmacists' perspective. [PDF]

Front Pharmacol
Zaprutko T, Kus K, Kremin Y, Hromovyk B, Lebanova H, Krajnović DM, Stević I, Simić E, Dorykevych K, Cynar J, Eliasz W, Cavaco AM.   +11 more
europepmc   +1 more source

Physician Perspectives on Pharmaceutical Promotion.

JAMA Health Forum
Mooney H, Austad K, Campbell EG, Avorn J, Lu Z, Kesselheim AS.   +5 more
europepmc   +1 more source

Correction: Burden of Disease and Treatment Gap in Patients with an Osteoporotic Hip Fracture between 2015 and 2019 in Italy. [PDF]

Drugs Aging
Scortichini M, Dilecce M, Spelta M, Sammak S, Riegler S, Bartolini F, Sciattella P.   +6 more
europepmc   +1 more source